| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
|
N Engl J Med
|
2005
|
8.49
|
|
2
|
The lifetime cost of current human immunodeficiency virus care in the United States.
|
Med Care
|
2006
|
5.87
|
|
3
|
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
|
N Engl J Med
|
2006
|
5.62
|
|
4
|
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
|
Ann Intern Med
|
2006
|
5.53
|
|
5
|
Loss to care and death before antiretroviral therapy in Durban, South Africa.
|
J Acquir Immune Defic Syndr
|
2009
|
5.40
|
|
6
|
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.
|
PLoS One
|
2010
|
4.75
|
|
7
|
Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
|
Clin Infect Dis
|
2010
|
3.96
|
|
8
|
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
|
AIDS
|
2010
|
3.93
|
|
9
|
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.
|
Clin Infect Dis
|
2009
|
3.89
|
|
10
|
Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume.
|
Arch Intern Med
|
2009
|
3.84
|
|
11
|
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.
|
Clin Infect Dis
|
2009
|
3.30
|
|
12
|
Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.
|
BMC Med
|
2011
|
3.08
|
|
13
|
Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department.
|
J Acquir Immune Defic Syndr
|
2007
|
2.91
|
|
14
|
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.
|
Am J Med
|
2003
|
2.48
|
|
15
|
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.
|
Clin Infect Dis
|
2005
|
2.47
|
|
16
|
Optimizing resource allocation in United States AIDS drug assistance programs.
|
Clin Infect Dis
|
2006
|
2.45
|
|
17
|
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
|
AIDS
|
2005
|
2.39
|
|
18
|
Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.
|
Clin Infect Dis
|
2012
|
2.38
|
|
19
|
Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans.
|
Ann Intern Med
|
2011
|
2.35
|
|
20
|
Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.
|
S Afr Med J
|
2008
|
2.30
|
|
21
|
HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.
|
J Acquir Immune Defic Syndr
|
2009
|
2.24
|
|
22
|
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.
|
Antivir Ther
|
2009
|
2.18
|
|
23
|
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
|
PLoS Med
|
2009
|
2.13
|
|
24
|
Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy.
|
JAMA Intern Med
|
2013
|
2.10
|
|
25
|
Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.
|
Clin Infect Dis
|
2009
|
2.05
|
|
26
|
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.
|
Proc Natl Acad Sci U S A
|
2006
|
2.00
|
|
27
|
Managing the demand for global health education.
|
PLoS Med
|
2011
|
1.96
|
|
28
|
Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.
|
Clin Infect Dis
|
2012
|
1.90
|
|
29
|
Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.
|
Clin Infect Dis
|
2004
|
1.78
|
|
30
|
Global health training in US graduate psychiatric education.
|
Acad Psychiatry
|
2014
|
1.78
|
|
31
|
Refusing HIV testing in an urgent care setting: results from the "Think HIV" program.
|
AIDS Patient Care STDS
|
2006
|
1.76
|
|
32
|
Cost-effectiveness of genotype testing for primary resistance in Brazil.
|
J Acquir Immune Defic Syndr
|
2015
|
1.73
|
|
33
|
Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.
|
AIDS
|
2012
|
1.71
|
|
34
|
Integrating HIV screening into routine health care in resource-limited settings.
|
Clin Infect Dis
|
2010
|
1.70
|
|
35
|
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa.
|
Clin Infect Dis
|
2003
|
1.69
|
|
36
|
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count.
|
S Afr Med J
|
2011
|
1.65
|
|
37
|
Scope of global health training in U.S. obstetrics and gynecology residency programs.
|
Obstet Gynecol
|
2013
|
1.64
|
|
38
|
WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
|
PLoS One
|
2011
|
1.63
|
|
39
|
The lifetime medical cost savings from preventing HIV in the United States.
|
Med Care
|
2015
|
1.61
|
|
40
|
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.
|
AIDS
|
2008
|
1.59
|
|
41
|
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness.
|
J Acquir Immune Defic Syndr
|
2010
|
1.57
|
|
42
|
Emergency provider attitudes and barriers to universal HIV testing in the emergency department.
|
J Emerg Med
|
2009
|
1.57
|
|
43
|
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.
|
AIDS
|
2012
|
1.57
|
|
44
|
Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction.
|
Clin Infect Dis
|
2013
|
1.57
|
|
45
|
HIV self-testing and the missing linkage.
|
PLoS Med
|
2011
|
1.57
|
|
46
|
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.
|
Clin Infect Dis
|
2010
|
1.55
|
|
47
|
Home testing for HIV infection in resource-limited settings.
|
Curr HIV/AIDS Rep
|
2009
|
1.54
|
|
48
|
Frequent HIV testing among participants of a routine HIV testing program.
|
Virulence
|
2010
|
1.53
|
|
49
|
What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
|
PLoS Med
|
2012
|
1.53
|
|
50
|
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
|
AIDS
|
2015
|
1.49
|
|
51
|
Routine HIV screening in France: clinical impact and cost-effectiveness.
|
PLoS One
|
2010
|
1.46
|
|
52
|
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men.
|
Clin Infect Dis
|
2007
|
1.43
|
|
53
|
Visual screening for malignant melanoma: a cost-effectiveness analysis.
|
Arch Dermatol
|
2007
|
1.41
|
|
54
|
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.
|
AIDS
|
2012
|
1.40
|
|
55
|
Barriers to care among people living with HIV in South Africa: contrasts between patient and healthcare provider perspectives.
|
AIDS Care
|
2012
|
1.35
|
|
56
|
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
|
AIDS
|
2007
|
1.34
|
|
57
|
Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
|
BMC Infect Dis
|
2014
|
1.32
|
|
58
|
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa.
|
PLoS One
|
2013
|
1.28
|
|
59
|
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
|
AIDS
|
2012
|
1.26
|
|
60
|
Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.
|
Arthritis Care Res (Hoboken)
|
2015
|
1.23
|
|
61
|
The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
|
Clin Infect Dis
|
2012
|
1.21
|
|
62
|
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
|
J Acquir Immune Defic Syndr
|
2012
|
1.17
|
|
63
|
Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa.
|
PLoS One
|
2013
|
1.14
|
|
64
|
Factors associated with refusal of rapid HIV testing in an emergency department.
|
AIDS Behav
|
2011
|
1.13
|
|
65
|
Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care.
|
J Infect Dis
|
2012
|
1.12
|
|
66
|
Home HIV testing: good news but not a game changer.
|
Ann Intern Med
|
2012
|
1.12
|
|
67
|
Does modality of survey administration impact data quality: audio computer assisted self interview (ACASI) versus self-administered pen and paper?
|
PLoS One
|
2010
|
1.11
|
|
68
|
Monitoring of antiretroviral therapy in low-resource settings.
|
Lancet
|
2008
|
1.11
|
|
69
|
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
|
AIDS
|
2011
|
1.10
|
|
70
|
Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
|
AIDS
|
2008
|
1.09
|
|
71
|
Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa.
|
AIDS Behav
|
2012
|
1.08
|
|
72
|
Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review.
|
BMC Infect Dis
|
2014
|
1.04
|
|
73
|
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.
|
AIDS
|
2012
|
1.03
|
|
74
|
Effectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overview.
|
Clin Infect Dis
|
2004
|
1.03
|
|
75
|
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease.
|
J Acquir Immune Defic Syndr
|
2005
|
1.01
|
|
76
|
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.
|
Drug Alcohol Depend
|
2012
|
1.01
|
|
77
|
Routine HIV testing in adolescents and young adults presenting to an outpatient clinic in Durban, South Africa.
|
PLoS One
|
2012
|
1.00
|
|
78
|
Implementing a routine, voluntary HIV testing program in a Massachusetts county prison.
|
J Urban Health
|
2006
|
0.99
|
|
79
|
The survival benefits of antiretroviral therapy in South Africa.
|
J Infect Dis
|
2013
|
0.98
|
|
80
|
Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
|
Antivir Ther
|
2005
|
0.98
|
|
81
|
A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial.
|
BMC Infect Dis
|
2013
|
0.98
|
|
82
|
Improving outcomes in state AIDS drug assistance programs.
|
J Acquir Immune Defic Syndr
|
2009
|
0.96
|
|
83
|
HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing.
|
Clin Infect Dis
|
2008
|
0.95
|
|
84
|
Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: the patient access managers' perspective.
|
Infect Control Hosp Epidemiol
|
2012
|
0.94
|
|
85
|
Therapeutic drug monitoring in HIV treatment: a literature review.
|
HIV Clin Trials
|
2006
|
0.93
|
|
86
|
Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.
|
Antivir Ther
|
2012
|
0.92
|
|
87
|
The acceptability and feasibility of routine pediatric HIV testing in an outpatient clinic in Durban, South Africa.
|
Pediatr Infect Dis J
|
2013
|
0.91
|
|
88
|
Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
|
PLoS One
|
2013
|
0.91
|
|
89
|
Acceptability of fingerstick versus oral fluid rapid HIV testing: results from the universal screening for HIV infection in the emergency room (USHER Phase II) randomized controlled trial.
|
J Acquir Immune Defic Syndr
|
2012
|
0.89
|
|
90
|
Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis.
|
Clin Infect Dis
|
2013
|
0.89
|
|
91
|
Clinic-based routine voluntary HIV testing in a refugee settlement in Uganda.
|
J Acquir Immune Defic Syndr
|
2014
|
0.89
|
|
92
|
Cost-effectiveness analysis and HIV screening: the emergency medicine perspective.
|
Ann Emerg Med
|
2011
|
0.89
|
|
93
|
Assessing the impact of federal HIV prevention spending on HIV testing and awareness.
|
Am J Public Health
|
2006
|
0.88
|
|
94
|
National survey of infection preventionists: policies for discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.
|
Infect Control Hosp Epidemiol
|
2012
|
0.88
|
|
95
|
Patient satisfaction with rapid HIV testing in the emergency department.
|
Ann Emerg Med
|
2011
|
0.88
|
|
96
|
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
|
PLoS One
|
2012
|
0.86
|
|
97
|
Rapid HIV testing program implementation: lessons from the emergency department.
|
Int J Emerg Med
|
2009
|
0.86
|
|
98
|
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.
|
PLoS One
|
2010
|
0.84
|
|
99
|
Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis.
|
Value Health
|
2010
|
0.83
|
|
100
|
Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa.
|
PLoS One
|
2013
|
0.83
|
|
101
|
Implications and impact of the new US Centers for Disease Control and prevention HIV testing guidelines.
|
Curr Infect Dis Rep
|
2008
|
0.83
|
|
102
|
Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost.
|
Clin Infect Dis
|
2006
|
0.83
|
|
103
|
Expanding provider-initiated HIV testing at STI clinics in China.
|
AIDS Care
|
2012
|
0.81
|
|
104
|
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.
|
N Engl J Med
|
2014
|
0.80
|
|
105
|
Photo quiz. An HIV-infected man with an upset stomach.
|
Clin Infect Dis
|
2008
|
0.79
|
|
106
|
Investing in People Who Inject Drugs: A PrEPonderance of Opportunities.
|
Ann Intern Med
|
2016
|
0.79
|
|
107
|
Testing for HIV infection in the United States.
|
Curr Infect Dis Rep
|
2007
|
0.79
|
|
108
|
What is a modest public health impact?
|
Arch Intern Med
|
2012
|
0.79
|
|
109
|
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.
|
Antivir Ther
|
2010
|
0.79
|
|
110
|
Estimation of the prevalence of undiagnosed and diagnosed HIV in an urban emergency department.
|
PLoS One
|
2011
|
0.78
|
|
111
|
Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
|
112
|
Missed opportunities: refusal to confirm reactive rapid HIV tests in the emergency department.
|
PLoS One
|
2013
|
0.78
|
|
113
|
Cost-effectiveness of generic antiretroviral therapy--in response.
|
Ann Intern Med
|
2013
|
0.78
|
|
114
|
The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.
|
Ann Intern Med
|
2016
|
0.78
|
|
115
|
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
|
J Acquir Immune Defic Syndr
|
2014
|
0.77
|
|
116
|
Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness.
|
N Engl J Med
|
2006
|
0.77
|
|
117
|
Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival.
|
AIDS
|
2014
|
0.76
|
|
118
|
High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy.
|
J Acquir Immune Defic Syndr
|
2013
|
0.76
|
|
119
|
Concordance of PCR and culture from nasal swabs for detection of methicillin-resistant Staphylococcus aureus in a setting of concurrent antistaphylococcal antibiotics.
|
J Clin Microbiol
|
2014
|
0.76
|
|
120
|
Projected survival gains from revising state laws requiring written opt-in consent for HIV testing.
|
J Gen Intern Med
|
2011
|
0.75
|
|
121
|
Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
|
122
|
Barriers to care and 1-year mortality among newly-diagnosed HIV-infected people in Durban, South Africa.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
123
|
Prevalence and correlates of clinically significant depressive symptoms in an urban hospital emergency department.
|
Prim Care Companion J Clin Psychiatry
|
2010
|
0.75
|
|
124
|
In reply.
|
Obstet Gynecol
|
2014
|
0.75
|
|
125
|
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.
|
HIV Clin Trials
|
2015
|
0.75
|
|
126
|
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
|
PLoS One
|
2012
|
0.75
|
|
127
|
Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.
|
HIV Clin Trials
|
2009
|
0.75
|
|
128
|
Vesiculopapular rash.
|
Clin Infect Dis
|
2006
|
0.75
|
|
129
|
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
|
AIDS
|
2017
|
0.75
|
|
130
|
The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations.
|
AIDS
|
2017
|
0.75
|
|
131
|
APTIMA assay approved for HIV testing.
|
AIDS Clin Care
|
2006
|
0.75
|